Recent technological advances in DNA sequencing have enabled a more detailed understanding of the molecular changes that define gynecological tumors [17], and the association between TPX2 overexpression and copy number amplification has been reported in malignant tumors of the ovaries and cervix [18,19]. This evidence concerns the gene TPX2 and cancer.